UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 800

Sortiert nach

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial

American journal of obstetrics and gynecology, 2016-06, Vol.214 (6), p.720.e1-720.e17

2016

Volltextzugriff (PDF)

A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia

American journal of obstetrics and gynecology, 2021-12, Vol.225 (6), p.666.e1-666.e15

2021

Volltextzugriff (PDF)

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Journal of hepatology, 2019-09, Vol.71 (3), p.516-522

2019

Volltextzugriff (PDF)

Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia

Hypertension (Dallas, Tex. 1979), 2015-09, Vol.66 (3), p.687-697

2015

Volltextzugriff (PDF)

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

Pharmacogenetics and genomics, 2007-08, Vol.17 (8), p.647-656

2007

Volltextzugriff (PDF)

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Pharmaceutical research, 2012-10, Vol.29 (10), p.2860-2873

2012

Volltextzugriff (PDF)

Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome

Circulation (New York, N.Y.), 2014-07, Vol.130 (1), p.27-34

2014

Volltextzugriff (PDF)

Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Clinical pharmacology and therapeutics, 2011-10, Vol.90 (4), p.575-581

2011

Volltextzugriff (PDF)

Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

Circulation (New York, N.Y.), 2021-08, Vol.144 (9), p.670-679

2021

Volltextzugriff (PDF)

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.2933-2940

2016

Volltextzugriff (PDF)

Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial

BJOG : an international journal of obstetrics and gynaecology, 2020-03, Vol.127 (4), p.478-488

2020

Volltextzugriff (PDF)

Statins for the prevention of dementia

Cochrane database of systematic reviews, 2016-01, Vol.2016 (1), p.CD003160-CD003160

2016

Volltextzugriff (PDF)

Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling

Drug metabolism and disposition, 2012-05, Vol.40 (5), p.892

2012

Volltextzugriff (PDF)

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)

The American journal of cardiology, 2003-07, Vol.92 (2), p.152-160

2003

Volltextzugriff (PDF)

Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study

Annals of internal medicine, 2019-01, Vol.170 (1), p.1

2019

Volltextzugriff (PDF)

Evidence for Inverse Effects of OATP‐C (SLC21A6) 5 and 1b Haplotypes on Pravastatin Kinetics

Clinical pharmacology and therapeutics, 2004-05, Vol.75 (5), p.415-421

2004

Volltextzugriff (PDF)

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

The New England journal of medicine, 2019-10, Vol.381 (16), p.1547-1556

2019

Volltextzugriff (PDF)

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia

British journal of haematology, 2014-10, Vol.167 (2), p.233-237

2014

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of the Interaction between Hepatitis C Virus Protease Inhibitor Boceprevir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Pravastatin

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2582-2588

2013

Volltextzugriff (PDF)

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

Pharmacogenomics, 2009-10, Vol.10 (10), p.1617-1624

2009

Volltextzugriff (PDF)

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

Clinical pharmacology and therapeutics, 2006-05, Vol.79 (5), p.427-439

2006

Volltextzugriff (PDF)

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

The New England journal of medicine, 1998-11, Vol.339 (19), p.1349-1357

1998

Volltextzugriff (PDF)

Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas

BMC pregnancy and childbirth, 2019-11, Vol.19 (1), p.426-426, Article 426

2019

Volltextzugriff (PDF)

What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial

Circulation (New York, N.Y.), 2010-11, Vol.122 (21), p.2142-2151

2010

Volltextzugriff (PDF)

SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patients

British journal of clinical pharmacology, 2007-09, Vol.64 (3), p.346-352

2007

Volltextzugriff (PDF)

1 – 25 von 800

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(728)
Mit Volltextzugriff
(611)

Publikationsform

Artikel
(800)

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(800)
Male
(699)
Female
(641)
Middle Aged
(636)
Science & Technology
(603)
Life Sciences & Biomedicine
(593)
Pravastatin - Therapeutic Use
(481)
Aged
(469)
Biological And Medical Sciences
(415)
Medical Sciences
(411)
Pharmacology. Drug Treatments
(302)
Pravastatin
(275)
Anticholesteremic Agents - Therapeutic Use
(252)
Hypercholesterolemia - Drug Therapy
(230)
Cardiovascular System & Cardiology
(210)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(207)
General And Cellular Metabolism. Vitamins
(200)
Cholesterol - Blood
(193)
Cholesterol, Ldl - Blood
(189)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial

A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome

Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial

Statins for the prevention of dementia

Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)

Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study

Evidence for Inverse Effects of OATP‐C (SLC21A6) 5 and 1b Haplotypes on Pravastatin Kinetics

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia

Pharmacokinetic Evaluation of the Interaction between Hepatitis C Virus Protease Inhibitor Boceprevir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Pravastatin

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas

What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial

SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patients

Aktive Filter

Suchergebnisse filtern